Review Of Novel Transdermal Platform for Efficient Rheumatoid Arthritis Treatment

Read full text Summarise with VIRAT
Authors: Akshay Nemade*, Vanita Pawar, Shraddha Pawar, Shruti Pinglaskar, Rushikesh Sakhare, Suchismita Sahoo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder characterized by persistent synovial inflammation, cartilage degradation, and progressive joint damage, which ultimately leads to functional disability and reduced quality of life. Conventional management primarily involves disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and sulfasalazine administered through oral or parenteral routes. Although these therapies are effective in controlling disease progression, long-term administration is frequently associated with gastrointestinal irritation, systemic adverse effects, fluctuating plasma drug levels, and reduced patient compliance. Transdermal drug delivery systems (TDDS) have emerged as a promising alternative approach that enables controlled and sustained drug release while bypassing hepatic first-pass metabolism and minimizing gastrointestinal complications. Several studies have reported the development of transdermal delivery systems for anti-rheumatic drugs to improve therapeutic efficiency and maintain stable plasma drug concentrations. The combination of methotrexate and sulfasalazine has demonstrated synergistic therapeutic effects through complementary anti-inflammatory and immunomodulatory mechanisms. Furthermore, recent advancements such as microneedle-assisted delivery, iontophoresis, and nanocarrier-based systems have enhanced drug permeation through the skin and improved the overall effectiveness of TDDS. This review highlights the therapeutic potential, formulation considerations, advantages, challenges, and future perspectives of transdermal combination therapy for improved management of rheumatoid arthritis

Fields of Study & Subjects

Advancements in Transdermal Drug Delivery Advanced Drug Delivery Systems Rheumatoid Arthritis Research and Therapies

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
21 March 2026
Language
EN